Hospital-Onset SARS-CoV-2 Infection During Omicron Linked to Morbidity

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

MONDAY, July 15, 2024 -- During the omicron era, hospital-onset severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection remained associated with increased morbidity and mortality, according to a study published online July 16 in the Annals of Internal Medicine.

Michael Klompas, M.D., M.P.H., from Harvard Medical School and the Harvard Pilgrim Health Care Institute in Boston, and colleagues estimated the effect of nosocomial SARS-CoV-2 infection on hospitalized patients' outcomes during the pre-omicron and omicron eras. Hospital mortality and time to discharge were assessed as primary outcomes among adults testing positive for SARS-CoV-2 on or after hospital day 5, after negative SARS-CoV-2 test results on admission and on hospital day 3, and matched control participants.

Data were included for 274 cases of hospital-onset SARS-CoV-2 infection during the pre-omicron period and 1,037 cases during the omicron period (0.17 and 0.49 cases per 100 admissions, respectively). The researchers found that compared with those without, patients with hospital-onset SARS-CoV-2 were older and had more comorbid conditions. During the pre-omicron period, compared with control participants, hospital-onset SARS-CoV-2 infection was associated with an increased risk for intensive care unit (ICU) admission, an increased need for high-flow oxygen, longer time to discharge (median difference, 4.7 days), and higher mortality (risk ratio, 2.0). During the omicron period, an increased risk for ICU admission and increased time to discharge (median difference, 4.2 days) were still seen in association with hospital-onset SARS-CoV-2. The association with increased hospital mortality was still significant, although attenuated (risk ratio, 1.6).

"The frequency and persistent morbidity associated with hospital-onset SARS-CoV-2 infections in the omicron era suggest that hospitals should implement measures to prevent nosocomial SARS-CoV-2 infections," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-07-16 07:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords